Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · Real-Time Price · USD
126.20
-0.06 (-0.05%)
At close: Jan 17, 2025, 4:00 PM
126.08
-0.13 (-0.10%)
After-hours: Jan 17, 2025, 5:47 PM EST

Intra-Cellular Therapies Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for ITCI stock have an average target of 100.31, with a low estimate of 74 and a high estimate of 132. The average target predicts a decrease of -20.52% from the current stock price of 126.20.

Analyst Consensus: Buy
Target Low Average Median High
Price $74 $100.31 $100 $132
Change -41.36% -20.52% -20.76% +4.60%

Analyst Ratings

The average analyst rating for ITCI stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Aug '24Sep '24Oct '24Nov '24Dec '24Jan '25
Strong Buy 555554
Buy 445555
Hold 222224
Sell 000000
Strong Sell 000000
Total 111112121213

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Piper Sandler
Piper Sandler
Hold
Downgrades
$107$132
Hold Downgrades $107$132 +4.60% Jan 14, 2025
Needham
Needham
Hold
Downgrades
$100
Hold Downgrades $100 -20.76% Jan 13, 2025
JP Morgan
JP Morgan
Buy
Maintains
$81$89
Buy Maintains $81$89 -29.48% Nov 4, 2024
Needham
Needham
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 -20.76% Oct 31, 2024
Needham
Needham
Strong Buy
Reiterates
$100
Strong Buy Reiterates $100 -20.76% Oct 30, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
689.19M
from 464.37M
Increased by 48.41%
Revenue Next Year
952.84M
from 689.19M
Increased by 38.26%
EPS This Year
-0.71
from -1.46
EPS Next Year
0.38
from -0.71
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
60.61K22.81M83.80M250.31M464.37M689.19M952.84M1.45B
Revenue Growth
-37,537.14%267.35%198.69%85.51%48.41%38.26%52.39%
EPS
-2.68-3.23-3.50-2.72-1.46-0.710.383.81
EPS Growth
-------895.28%
Forward PE
------330.0633.16
No. Analysts -----171715
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026202720282029
High 715.1M 1.1B 1.7B
Avg 689.2M 952.8M 1.5B
Low 656.2M 839.9M 1.1B

Revenue Growth

Revenue Growth 202420252026202720282029
High
54.0%
55.4%
82.5%
Avg
48.4%
38.3%
52.4%
Low
41.3%
21.9%
15.5%

EPS Forecast

EPS 202420252026202720282029
High -0.37 1.39 6.33
Avg -0.71 0.38 3.81
Low -1.04 -0.92 1.46

EPS Growth

EPS Growth 202420252026202720282029
High - -
1,555.9%
Avg - -
895.3%
Low - -
281.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.